[
    [
        {
            "time": "",
            "original_text": "现实版“药神”上市！目前仍然巨亏，市值却碾压A股99%医药公司，其美股两年翻10倍 重大损失",
            "features": {
                "keywords": [
                    "药神",
                    "上市",
                    "巨亏",
                    "市值",
                    "美股",
                    "两年翻10倍",
                    "重大损失"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "现实版“药神”上市！目前仍然巨亏，市值却碾压A股99%医药公司，其美股两年翻10倍 重大损失",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药行业周报：国家医保局：新一轮抗癌药医保准入谈判下月完成",
            "features": {
                "keywords": [
                    "医药行业",
                    "国家医保局",
                    "抗癌药",
                    "医保准入",
                    "谈判"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业周报：国家医保局：新一轮抗癌药医保准入谈判下月完成",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医疗保健：2018年医疗器械行业标准制修订项目公布",
            "features": {
                "keywords": [
                    "医疗保健",
                    "2018年",
                    "医疗器械",
                    "行业标准",
                    "制修订"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医疗保健：2018年医疗器械行业标准制修订项目公布",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        }
    ]
]